These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Heterogeneous amyloid-formed ion channels as a common cytotoxic mechanism: implications for therapeutic strategies against amyloidosis. Kourie JI, Culverson AL, Farrelly PV, Henry CL, Laohachai KN. Cell Biochem Biophys; 2002; 36(2-3):191-207. PubMed ID: 12139405 [Abstract] [Full Text] [Related]
10. Study of the correlation of secondary structure of beta-amyloid peptide (Abeta40) with the hydrophobic exposure under different conditions. Ji SR, Wu Y, Sui SF. Gen Physiol Biophys; 2002 Dec 24; 21(4):415-27. PubMed ID: 12693713 [Abstract] [Full Text] [Related]
11. Displacement currents associated with the insertion of Alzheimer disease amyloid beta-peptide into planar bilayer membranes. Vargas J, Alarcón JM, Rojas E. Biophys J; 2000 Aug 24; 79(2):934-44. PubMed ID: 10920024 [Abstract] [Full Text] [Related]
15. Study of the specific lipid binding properties of Abeta 11-22 fragment at endosomal pH. Ravault S, Flore C, Saurel O, Milon A, Brasseur R, Lins L. Langmuir; 2009 Sep 15; 25(18):10948-53. PubMed ID: 19735146 [Abstract] [Full Text] [Related]
17. Cardiolipin, phosphatidylserine, and BH4 domain of Bcl-2 family regulate Ca2+/H+ antiporter activity of human Bax inhibitor-1. Ahn T, Yun CH, Kim HR, Chae HJ. Cell Calcium; 2010 Apr 15; 47(4):387-96. PubMed ID: 20193962 [Abstract] [Full Text] [Related]
18. Why is the amyloid beta peptide of Alzheimer's disease neurotoxic? Rauk A. Dalton Trans; 2008 Mar 14; (10):1273-82. PubMed ID: 18305836 [Abstract] [Full Text] [Related]
19. Interactions of histone H1 with phospholipids and comparison of its binding to giant liposomes and human leukemic T cells. Zhao H, Bose S, Tuominen EK, Kinnunen PK. Biochemistry; 2004 Aug 10; 43(31):10192-202. PubMed ID: 15287747 [Abstract] [Full Text] [Related]
20. Physiological and biophysical factors that influence Alzheimer's disease amyloid plaque targeting of native and putrescine modified human amyloid beta40. Kandimalla KK, Curran GL, Holasek SS, Gilles EJ, Wengenack TM, Ramirez-Alvarado M, Poduslo JF. J Pharmacol Exp Ther; 2006 Jul 10; 318(1):17-25. PubMed ID: 16565169 [Abstract] [Full Text] [Related] Page: [Next] [New Search]